HomeTVTX • NASDAQ
add
Travere Therapeutics Inc
Previous close
$19.80
Day range
$19.20 - $20.00
Year range
$5.12 - $25.29
Market cap
1.66B USD
Avg Volume
1.78M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 74.79M | 65.98% |
Operating expense | 69.50M | 9.30% |
Net income | -60.26M | 33.17% |
Net profit margin | -80.58 | 59.73% |
Earnings per share | -0.47 | 50.00% |
EBITDA | -47.24M | 35.59% |
Effective tax rate | 0.12% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 370.70M | -34.60% |
Total assets | 594.12M | -24.69% |
Total liabilities | 535.05M | -9.02% |
Total equity | 59.08M | — |
Shares outstanding | 88.74M | — |
Price to book | 29.12 | — |
Return on assets | -27.01% | — |
Return on capital | -35.63% | — |
Cash Flow
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -60.26M | 33.17% |
Cash from operations | -35.72M | 49.31% |
Cash from investing | -80.31M | -373.80% |
Cash from financing | 139.12M | 112,092.74% |
Net change in cash | 22.13M | 125.71% |
Free cash flow | -13.55M | -1,509.19% |
About
Founded
2008
Website
Employees
385